• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy House Republicans ask DEA, CBP to get ‘zombie drug’ off the streets
Economy

House Republicans ask DEA, CBP to get ‘zombie drug’ off the streets

by January 16, 2023
by January 16, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

EXCLUSIVE: House Republican lawmakers are asking the Drug and Enforcement Administration (DEA) and Customs and Border Protection (CBP) to do more to get xylazine, sometimes called the ‘zombie drug,’ off streets where drug dealers are abusing the substance by combining the animal tranquilizer with fentanyl for a deadly combination, exacerbating the fentanyl crisis.

Reps. Jim Banks, R-Ind., Kat Cammack, R-Fla., and August Plfuger, R-Texas, wrote to DEA Administrator Anne Milgram and Acting CBP Commissioner Troy Miller Monday in a letter reviewed exclusively by Fox News Digital, asking the agencies to schedule xylazine, the animal tranquilizer drug, to properly recognize the drug as ‘the threat that it is.’ 

The lawmakers called government’s response so far to the damage the drug is causing is ‘wholly inadequate.’ Banks says if the White House fails to address the problem, House Republicans will introduce legislation. 

‘For once, I hope the Biden administration moves quickly to fight the deadly drug crisis in this country. If they don’t, House Republicans will introduce legislation to schedule Xylazine,’ Banks told Fox News Digital in a statement. 

‘The fentanyl crisis has already inflicted significant damage on our treatment clinics and programs, public health agencies, and our entire medical system,’ the lawmakers wrote. ‘The addition of yet another highly toxic and addictive substance to the illicit drug supply will only further escalate this crisis. It is of the utmost importance that all relevant agencies mount an active and energetic response to this emerging threat.’

‘As you may know, xylazine, also known by street names ‘tranq’ and ‘zombie drug,’ has emerged as an increasingly popular drug to combine with fentanyl to intensify drug effects and lower costs,’ the lawmakers wrote. 

‘The effects of xylazine are devastating and include severe necrotic skin ulcerations that often lead to amputation, and severe withdrawal symptoms that leave users trapped in a vicious cycle of addiction,’ they said.

According to the lawmakers, the drug is not detected by current toxicology screens, and, in cases of overdose, naloxone is not known to be effective.

A spokesperson for the DEA told Fox News Digital that the two-part process to schedule a substance has been in the works since October 2021. That process involves sending a data review to the Department of Health and Human Services (HHS) and a request to HHS for a scheduling recommendation for xylazine.

In an effort to signal to HHS DEA’s growing concern with xylazine, DEA sent supplemental information in September 2022 to the agency in hopes to accelerate the scheduling processing. DEA is still waiting on HHS to provide a scheduling recommendation. 

‘The men and women of the DEA are relentlessly working to save American lives by stopping trafficking of xylazine and other deadly synthetic drugs,’ the spokesperson said, adding that they are looking forward to the completion of HHS’ scheduling recommendation. 

The lawmakers say that significant amounts of xylazine have already been found in drug samples in 36 states and the District of Columbia. Hospitals from across the country are reporting an increase in the prevalence of the drug.

In New York City, xylazine has been found in 25% of drug samples, though health officials say the actual number is likely much higher, the lawmakers claim. One estimate, the say, done in Philadelphia in 2021 found xylazine present in over 90% of fentanyl and heroin samples.

The lawmakers are asking the DEA to start the process of scheduling xylazine, according to the Controlled Substance Act if that process has not already been started, and for further details related to what the DEA is planning to stop xylazine’s illicit use. 

According to the DEA, ‘substances are placed in their respective schedules based on whether they have a currently accepted medical use in treatment in the United States, their relative abuse potential, and likelihood of causing dependence when abused.’

The House Republicans are also asking to what extent CBP is scrutinizing shipments from China.

The agencies have until Jan. 20 to respond. 

Brianna Herlihy is a politics writer for Fox News Digital.

This post appeared first on FOX NEWS
You Might Also Like
  • Amazon stock decline with margin after Q1 Sales Outlook
  • Trump to meet with House, Senate Republicans in DC this week
  • US floats possible plan for postwar Gaza, who could govern after Israel eliminates Hamas
  • House to attempt to expel George Santos for a third time, as Johnson says members will ‘vote their conscience’
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Alabama Gov. Kay Ivey sworn in for 2nd full term
next post
Biden takes swipe at Second Amendment supporters: ‘You need F-15s’ to take on the federal government

You may also like

Special counsel Jack Smith proposes ‘narrowly tailored’ gag order on...

September 16, 2023

Biden ‘working the phones’ in battle to save re-election bid,...

July 9, 2024

Kansas man on trial for threatening congressman cross-examines him in...

January 19, 2023

House GOP eyes election safeguards to block ‘dangerously high number’...

May 9, 2024

House GOP seeking to expunge ‘sham’ Trump impeachments

June 23, 2023

Who wants to tear down Mt. Rushmore?

January 20, 2023

Harris was ‘reluctant’ to choose Shapiro because of his ‘Jewish...

August 7, 2024

DNC insider claims Biden meeting with Obama, Democratic strategist following...

June 29, 2024

US, Israel unsure how many Hamas hostages are ‘still alive,’...

November 13, 2023

Fox News Poll: Voters blame Hamas for war, continue to...

November 16, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Don’t Overlook This Lagging Industry; I Believe It’s Set To Explode!

      July 6, 2025
    • Week Ahead: NIFTY Set To Stay In A Defined Range Unless These Levels Are Taken Out; Drags Support Higher

      July 5, 2025
    • Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

      July 4, 2025
    • From Oversold to Opportunity: Small Caps on the Move

      July 3, 2025
    • Money’s Not Leaving the Market — It’s Rotating!

      July 3, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,629 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,916 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,604 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,571 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,445 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,163)
    • Investing (538)
    • Stock (2,654)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Don’t Overlook This Lagging Industry; I Believe It’s Set To...

      July 6, 2025
    • Week Ahead: NIFTY Set To Stay In A Defined Range...

      July 5, 2025
    • Essence Fest leads a summer of events for Black entrepreneurs...

      July 4, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,163)
    • Investing (538)
    • Stock (2,654)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    White House doctor says Biden ‘fit...

    February 17, 2023

    Top Oversight Democrat slams GOP for...

    November 30, 2023

    Biden admin reverses Trump-era action making...

    September 16, 2023
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here